PCTY · Paylocity Holding Corporation · Stock research

Current Thesis

A post-print re-rating leg. The 2026-08-04 Q4 FY26 report beat on both lines (adj. EPS $1.84 vs $1.61 consensus; revenue $444.7M vs $430.9M), drew five sell-side price-target raises inside 48 hours, and left the stock at $150.42 on 2026-08-07 after a 35.5% three-month advance. What is being bought is multiple recovery in a mid-cap HCM software name that traded down to a compressed base — and it is being bought against an FY27 guide that steps recurring revenue growth from 12.2% to roughly 8%.

Bullish and bearish views on Paylocity Holding Corporation

The model's bull view on Paylocity Holding Corporation (PCTY), in brief: Q4 FY26 beat, 2026-08-04: total revenue $444.7M, +11.0% YoY; recurring & other revenue $415.6M, +12.4% YoY. The bear view: The growth step-down is the whole argument. Both cases follow in full.

Bull Case

• Q4 FY26 beat, 2026-08-04: total revenue $444.7M, +11.0% YoY; recurring & other revenue $415.6M, +12.4% YoY. Non-GAAP EPS $1.84 against a $1.61 estimate — a 14.2% beat.
• Guide cleared the bar: Q1 FY27 total revenue guided $439.5M–$444.5M versus the $438.482M consensus; Q1 recurring & other revenue $414.0M–$419.0M, described by the company as ~10% growth.
• FY27 profitability guide above FY26 actual: Adjusted EBITDA $690.0M–$700.0M for FY27, against FY26 Adjusted EBITDA of $654.9M (37.0% of revenue). Ex-client-fund-interest FY27 Adjusted EBITDA guided $587.0M–$597.0M.
• Cash generation: FY26 operating cash flow $533.3M (30.1% margin), free cash flow $427.8M (24.2% margin). Cash and equivalents $271.9M against long-term debt of $81.3M.
• The company is shrinking the share count: $398.1M / 2.8M shares repurchased in FY26; $697.8M / 4.6M shares cumulative since May 2024.
• Unit economics held on the 2026-08-04 call: average revenue per client ~$37,200, +5%; client base up roughly 7%; revenue retention above 92%. Management framed Paylocity Ignite AI as embedding agentic capability into core HCM workflows.
• Sell-side reset upward, all above spot: BTIG $180, KeyBanc $178, TD Cowen $168, Cantor Fitzgerald $165 (all 2026-08-05), Barclays $154 (2026-08-06) — versus the 2026-08-07 close of $150.42.

Bear Case

• The growth step-down is the whole argument. FY27 recurring & other revenue guided $1.777B–$1.792B, ~8% growth, against FY26 actual $1.651B, +12.2%. FY27 total revenue guided $1.880B–$1.895B, ~7% growth, against FY26 total revenue $1.771B, +11.0%.
• Total revenue is guided to grow slower than recurring revenue, which means client fund interest income — the float on client payroll balances — is guided down. That line moves with front-end rates and is outside management's control.
• Part of the FY27 margin guide is a convention change. Beginning FY27 the company amortizes deferred contract costs over 8 years instead of 7, disclosed 2026-08-04 as worth approximately 120–140 basis points to FY27 Adjusted EBITDA margin. FY27 margins are therefore not directly comparable to FY26.
• The reaction was modest relative to the beat: shares rose 3.1% on 2026-08-05 to $147.81 on a 14.2% EPS beat.
• Dispersion is wide. UBS held Neutral with a $128 target on 2026-07-22 — $52 below BTIG's $180. The bull and bear cases are not converging.
• Overhead supply is real: the 2026-08-07 close of $150.42 sits 18.1% below the 52-week high of $183.69. This leg is recovering ground previously lost, and every level between here and $183.69 has prior owners in it.
• Nothing company-specific resolves for roughly eleven weeks. The next hard print is Q1 FY27 in late October.

Setup & Price Structure

• Last completed daily close $150.42 (2026-08-07). 52-week high $183.69; distance from high -18.1%. Three-month return +35.5%. RSI(14) 71.1.
• Post-print behaviour: +3.1% to $147.81 on 2026-08-05, then higher into the 2026-08-07 close. The earnings gap has been held, not filled, through the price basis date.
• Life-cycle: ACCELERATING. Dated by the 2026-08-04 print, the five price-target raises on 2026-08-05 and 2026-08-06, and the 35.5% three-month advance. The qualification matters: attention and price are accelerating while the guided revenue growth rate is decelerating by roughly four points. Those two can co-exist for a while — a compressed multiple expanding on a lower growth rate is a normal recovery pattern — but it makes the leg dependent on multiple rather than on the growth line.
• Crowding and positioning observables (stated, not judged): RSI(14) at 71.1 on the price basis date; five price targets clustered $154–$180 raised within 48 hours of the print; the company repurchased $398.1M of stock in FY26 rather than issuing into strength; no scheduled company event inside the next 30 days to refresh the flow.
• Structural reference: the $140 area sits below the entire post-print trading zone. Losing it on a weekly basis would return the name inside its pre-earnings range and unwind the 2026-08-04 event.

Catalyst Calendar (next 30 days)

• ~2026-08-28 (est.) — FY26 Form 10-K. Standard large-accelerated-filer window after the June 30 fiscal year end. Carries the full-year revenue retention and client-fund disclosures, plus the accounting language on the 7-to-8-year deferred contract cost change.
• ~2026-09-04 (est.) — August US nonfarm payrolls. Paylocity bills partly per employee per month; mid-market employment levels flow into recurring revenue with a lag.
• ~2026-09-16 (est.) — FOMC decision. Client fund interest income is the rate-sensitive revenue line already guided lower for FY27.
• ~2026-10-29 (est.) — Q1 FY27 print. Outside the 30-day window, and named because the window is otherwise empty of company-specific events. This is where the ~10% Q1 recurring growth guide and the $1.777B FY27 floor get marked.

What Would Change Our Mind

The structure carrying this read is the 2026-08-04 earnings gap and the three-month base beneath it. If that gap fills and the name re-enters its pre-print range, the argument that the print reset expectations upward is gone — a weekly close below $140 is the gradeable form of that, and it would put price back where it stood before the beat.

On fundamentals, the specific datapoint that would flip the read is the Q1 FY27 print in late October: recurring & other revenue below the $414.0M guided floor, or any cut to the $1.777B FY27 recurring revenue floor. Either would establish that ~8% is a ceiling rather than a conservative starting point. A second marker is client fund interest income: total revenue guided at ~7% versus recurring at ~8% already implies contraction there, and a steeper decline would compress reported growth further regardless of how the core platform performs.

The upside marker that would strengthen the case is a reclaim of the $183.69 52-week high, which would mean the market is paying FY26's multiple on FY27's lower growth rate — a genuine re-rating rather than a mean reversion.

Correlation Notes

• Direct peer complex: Paycom (PAYC), ADP, Paychex (PAYX), Workday (WDAY). Payroll and HCM software names trade together on seat growth, float income and mid-market employment sentiment; a guide-down at any of them tends to pull the group's multiple.
• Rate channel: client fund interest income makes PCTY partially a front-end-rate asset. The FY27 guide already separates Adjusted EBITDA including ($690M–$700M) and excluding ($587M–$597M) client fund interest, which is the cleanest way to see how much of profitability rides on rates rather than software.
• Employment channel: per-employee-per-month billing ties revenue to client headcount. Monthly payroll and small-business employment data are the read-through, which is why the ~2026-09-04 print sits on the calendar despite not being a company event.
• Software beta: as a mid-cap SaaS name that has already de-rated 18.1% from its high and is recovering, PCTY carries above-index sensitivity to the broader software complex (IGV) on multiple-compression days.